Sertraline is a selective serotonin reuptake inhibitor (SSRI) antidepressant commonly associated with the brand name Zoloft®. It is used in the treatment of several psychiatric conditions involving mood, anxiety, and obsessive compulsive symptoms.
Sertraline works primarily by inhibiting the serotonin transporter (SERT), reducing the reuptake of serotonin, also known as 5 hydroxytryptamine or 5 HT, into presynaptic nerve cells. This increases serotonin availability within the synaptic space and enhances serotonergic signaling in areas of the brain involved in mood, anxiety, emotional regulation, and repetitive thought patterns.
Established indications for sertraline include major depressive disorder (MDD), obsessive compulsive disorder (OCD), and panic disorder. Depending on the jurisdiction and formulation, sertraline is also used for conditions including post traumatic stress disorder, social anxiety disorder, and premenstrual dysphoric disorder.
For depression, increased serotonergic signaling can help improve persistent low mood, loss of interest, and other symptoms associated with major depressive disorder. In OCD, sertraline can help reduce intrusive obsessive thoughts and repetitive compulsive behaviors. In panic disorder, continued treatment may reduce the frequency and severity of panic attacks and associated anxiety.
The therapeutic effects of sertraline generally develop gradually over several weeks rather than immediately. The response to treatment varies between individuals, and continued therapy may be recommended after symptoms improve to help maintain clinical benefit.
This product provides:
- Active Ingredient: Sertraline
- Form: Sertraline Hydrochloride
- Strength: 50mg per tablet
- Quantity: 100 Tablets
- Drug Class: Selective Serotonin Reuptake Inhibitor (SSRI)
- Dosage Form: Oral Tablet
- Common Uses: Depression, OCD and panic disorder
Sertraline has a relatively selective effect on serotonin reuptake compared with many older antidepressants. It has considerably weaker effects on norepinephrine and dopamine reuptake and does not produce its primary therapeutic activity through direct stimulation of serotonin receptors.
Common adverse effects can include nausea, diarrhea, headache, sweating, dizziness, insomnia or sleepiness, fatigue, tremor, and sexual dysfunction. Individual responses vary, and some side effects may become less noticeable as treatment continues.
Like other SSRIs, sertraline can contribute to serotonin syndrome when combined with other medications or substances that substantially increase serotonin activity. Monoamine oxidase inhibitors (MAOIs) should not be used concurrently with sertraline, and appropriate separation periods are required when switching between these medications.
SSRIs can also increase the risk of abnormal bleeding, particularly when combined with aspirin, NSAIDs, anticoagulants, or other medications that affect blood clotting. Other clinically important considerations include low sodium levels, activation of mania or hypomania in susceptible individuals, and seizure risk in certain patients.
Antidepressants carry an important warning regarding an increased risk of suicidal thoughts and behaviors in pediatric and young adult patients, particularly during early treatment or following changes in therapy. Patients should be monitored for worsening depression or significant behavioral changes.
Sertraline should generally not be discontinued abruptly after regular treatment. Gradual dose reduction is recommended where possible because sudden discontinuation can produce dizziness, irritability, anxiety, headache, sensory disturbances, nausea, and sleep changes.
Sertraline is a prescription medication and should be used according to the directions of a qualified healthcare professional.
